Diabetes-mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction

Fuente: Zenodo
Salvato in:
Dettagli Bibliografici
Autori principali: del Puerto Nevado, Laura, Santiago Hernandez, Aránzazu, Sonia Solanes Casado, González, Nieves, Marta Ricole Vila, Corton, Marta, Prieto, Isabel, Mas, Sebastian, Sanz, Ana Belen, aguilera, oscar, Gomez-Guerrero, Carmen, Ayuso, Carmen, Ortiz Arduan, Alberto, Rojo, Federico, Egido, Jesus, J, Garcia-Foncillas, Minguez, Pablo, Alvarez-Llamas, Gloria
Natura: Recurso digital
Lingua:inglese
Pubblicazione: Zenodo 2019
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1866901577556557824
author del Puerto Nevado, Laura
Santiago Hernandez, Aránzazu
Sonia Solanes Casado
González, Nieves
Marta Ricole Vila
Corton, Marta
Prieto, Isabel
Mas, Sebastian
Sanz, Ana Belen
aguilera, oscar
Gomez-Guerrero, Carmen
Ayuso, Carmen
Ortiz Arduan, Alberto
Rojo, Federico
Egido, Jesus
J, Garcia-Foncillas
Minguez, Pablo
Alvarez-Llamas, Gloria
author_facet del Puerto Nevado, Laura
Santiago Hernandez, Aránzazu
Sonia Solanes Casado
González, Nieves
Marta Ricole Vila
Corton, Marta
Prieto, Isabel
Mas, Sebastian
Sanz, Ana Belen
aguilera, oscar
Gomez-Guerrero, Carmen
Ayuso, Carmen
Ortiz Arduan, Alberto
Rojo, Federico
Egido, Jesus
J, Garcia-Foncillas
Minguez, Pablo
Alvarez-Llamas, Gloria
contents <p>Type 2 diabetes mellitus (T2DM) has been associated with an increased risk<br>of cancer, including colon cancer (CC). However, we recently reported no<br>influence of T2DM on CC prognosis, suggesting that any effect might be at<br>the early stages of tumor development. We hypothesized that T2DM may<br>create an environment in the healthy tissue, which acts as a carcinogenesis<br>driver in agreement with the field of cancerization concept. Here, we focused<br>on early carcinogenesis by analyzing paired tumor and normal colonic<br>mucosa samples from the same patients. The proteome of CC and paired<br>mucosa was quantitatively analyzed in 28 individuals (12 diabetics and 16<br>nondiabetics) by mass spectrometry with isobaric labeling. Out of 3076 identified<br>proteins, 425 were differentially expressed at the tumor in diabetics<br>compared with nondiabetics. In the adjacent mucosa, 143 proteins were differentially<br>expressed in diabetics and nondiabetics. An enrichment analysis<br>of this signature pointed to mitochondria, ribosome, and translation. Only<br>six proteins were upregulated by diabetes both in tumor and mucosa, of<br>which five were mitochondrial proteins. Differential expression in diabetic<br>versus nondiabetic mucosa was confirmed for MRPL53, MRPL18, and<br>TIMM8B. Higher levels of MRPL18, TIMM8B, and EIF1A were also found<br>in normal colon epithelial cells exposed to high-glucose conditions. We conclude<br>that T2DM is associated with specific molecular changes in the normal<br>mucosa of CC patients, consistent with field of cancerization in a diabetic<br>environment. The mitochondrial protein signature identifies a potential therapeutic<br>target that could underlie the higher risk of CC in diabetics.</p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_18772534
institution Zenodo
language eng
publishDate 2019
publisher Zenodo
record_format zenodo
spellingShingle Diabetes-mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction
del Puerto Nevado, Laura
Santiago Hernandez, Aránzazu
Sonia Solanes Casado
González, Nieves
Marta Ricole Vila
Corton, Marta
Prieto, Isabel
Mas, Sebastian
Sanz, Ana Belen
aguilera, oscar
Gomez-Guerrero, Carmen
Ayuso, Carmen
Ortiz Arduan, Alberto
Rojo, Federico
Egido, Jesus
J, Garcia-Foncillas
Minguez, Pablo
Alvarez-Llamas, Gloria
colon cancer; diabetes; field of cancerization; mitochondria; proteomics
<p>Type 2 diabetes mellitus (T2DM) has been associated with an increased risk<br>of cancer, including colon cancer (CC). However, we recently reported no<br>influence of T2DM on CC prognosis, suggesting that any effect might be at<br>the early stages of tumor development. We hypothesized that T2DM may<br>create an environment in the healthy tissue, which acts as a carcinogenesis<br>driver in agreement with the field of cancerization concept. Here, we focused<br>on early carcinogenesis by analyzing paired tumor and normal colonic<br>mucosa samples from the same patients. The proteome of CC and paired<br>mucosa was quantitatively analyzed in 28 individuals (12 diabetics and 16<br>nondiabetics) by mass spectrometry with isobaric labeling. Out of 3076 identified<br>proteins, 425 were differentially expressed at the tumor in diabetics<br>compared with nondiabetics. In the adjacent mucosa, 143 proteins were differentially<br>expressed in diabetics and nondiabetics. An enrichment analysis<br>of this signature pointed to mitochondria, ribosome, and translation. Only<br>six proteins were upregulated by diabetes both in tumor and mucosa, of<br>which five were mitochondrial proteins. Differential expression in diabetic<br>versus nondiabetic mucosa was confirmed for MRPL53, MRPL18, and<br>TIMM8B. Higher levels of MRPL18, TIMM8B, and EIF1A were also found<br>in normal colon epithelial cells exposed to high-glucose conditions. We conclude<br>that T2DM is associated with specific molecular changes in the normal<br>mucosa of CC patients, consistent with field of cancerization in a diabetic<br>environment. The mitochondrial protein signature identifies a potential therapeutic<br>target that could underlie the higher risk of CC in diabetics.</p>
title Diabetes-mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction
topic colon cancer; diabetes; field of cancerization; mitochondria; proteomics
url https://doi.org/10.5281/zenodo.18772534